GlucoTrack
(NASDAQ) GCTK
GlucoTrack Financials at a Glance
Market Cap
$2.57M
Revenue (TTM)
$0.00
Net Income (TTM)
-$16.89M
EPS (TTM)
-$20.88
P/E Ratio
-0.02
Dividend
$0.00
Beta (Volatility)
0.73 (Low)
Dividend
$0.00
Beta (Volatility)
0.73 (Low)
Price
$0.39
Volume
307,758.404
Open
$0.38
Price
$0.39
Volume
307,758.404
Open
$0.38
Previous Close
$0.41
Daily Range
$0.37 - $0.40
52-Week Range
$0.29 - $15.90
Estimated Earnings Date
Mar 30, 2026
Dividend
$0.00
Beta (Volatility)
0.73 (Low)
Price
$0.39
Volume
307,758.404
Open
$0.38
Previous Close
$0.41
Daily Range
$0.37 - $0.40
52-Week Range
$0.29 - $15.90
Estimated Earnings Date
Mar 30, 2026
GCTK News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout GlucoTrack
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
15
CEO
Paul V. Goode, PhD
Website
www.glucotrack.comHeadquarters
Or Yehuda, 7760049, IL
GCTK Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-527%
Return on Capital
13%
Return on Assets
-4%
Earnings Yield
-50.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.57M
Shares Outstanding
6.26M
Volume
307.76K
Avg. Volume
4.81M
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$16.09M
EBITDA
-$19.35M
Operating Cash Flow
-$15.24M
Capital Expenditure
-$96.00K
Free Cash Flow
-$15.34M
Cash & ST Invst.
$7.38M
Total Debt
$33.00K
GlucoTrack Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$22.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$2.57M
N/A
Market Cap/Employee
$233.30K
N/A
Employees
11
N/A
Net Income
-$4.33M
+36.6%
EBITDA
-$4.31M
+36.8%
Quarterly Fundamentals
Total Cash
$3.93M
-56.8%
Total Debt
$26.00K
-90.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$26.00K
-25.7%
Return on Assets
-3.88%
N/A
Return on Invested Capital
13.21%
N/A
Free Cash Flow
-$4.05M
-37.3%
Operating Cash Flow
-$4.05M
-37.7%